David J. Dabbs - Publications, H-index & Citations

David J. Dabbs

casi steering committee member

57H指数

379论文数

1.2W被引数

收录论文 73

发表时间

Development and cross-validation of a novel multi-omic assay to assess locoregional recurrence risk and adjuvant therapy benefit in early-stage hormone receptor positive invasive breast cancer patients 开发并交叉验证一种新型多组学检测方法，以评估早期激素受体阳性浸润性乳腺癌患者的局部区域复发风险及辅助治疗获益。

Breast Cancer Research

IF5.6

2026-02-18

OAAI

Troy Bremer; Karuna Mittal; Chirag Shah; Frank Vicini; Naamit K. Gerber; Melissa Krystel-Whittemore; Clayton C. Yates; Balasubramanyam Karanam; Walter Bell; Samuel G. Borak; Charles E. Cox; Abigail Beard; Geza Acs; Vincent Reid; Zahraa Al-Hilli; Steven C. Shivers; Mark Mentrikoski; David Dabbs; Jess Savala; Pat W. Whitworth; Charlotta Wadsten

New standards in HER2-low testing: the CASI-01 comparative methods study HER2-low检测的新标准：CASI-01比较方法研究

eBioMedicine

IF10.8

2025-09-12

PREAI

David J. Dabbs; Emina Torlakovic; Søren Nielsen; Suzanne C. Parry; Jing Yu; Catherine Stoos; Beth Clark; Henrik Høeg; Jeppe Thagaard; Seshi R. Sompuram; Stephen P. Naber; Yukako Yagi; James Sayre; Kodela Vani; Mélissande Cossutta; Francoise Soussaline; Alexandre Papine; Nils A. t'Hart; Matthias J. Szabolcs; Bharat Jasani; Mary Kinloch; Luis Chiriboga; Keith Miller; Steve Bogen

Limitations in the Application of Clinicopathologic Factors Alone in Predicting Radiation Benefit for Women with Low-Risk Ductal Carcinoma in Situ after Breast Conserving Surgery: The Impact of a 7-gene Biosignature based on 10-Year Ipsilateral Breast Recurrence (IBR) Rates 仅依靠临床病理因素预测行保乳术后低风险导管原位癌女性放疗获益的应用局限性：基于10年同侧乳腺复发(IBR)率的7基因生物标志物的影响

international journal of radiation oncology biology physics

IF0

2025-07-18

PREAI

Frank Vicini; Chirag Shah; Karuna Mittal; Sheila Weinmann; Michael Leo; G. Bruce Mann; Fredrik Warnberg; Rachel Rabinovitch; Brian Czerniecki; Icro Meattini; Atif Jalees Khan; Sachin Jhawar; Naamit Gerber; Shawna C. Willey; Pat Borgen; Zahraa AlHilli; Megan Kruse; David Dabbs; Steven C. Shivers; Anna Daily; Pat Whitworth; Michael Alvarado; Jason A. Mouabbi; Meena Moran; Hope Rugo; Joyce A. O’Shaughnessy; Troy Bremer

FGFR4 in endocrine resistance: overexpression and estrogen regulation without direct causative role

BREAST CANCER RESEARCH AND TREATMENT

IF3

2025-03-01

PREAI

Ding, Kai; Chen, Lyuqin; Levine, Kevin M.; Sikora, Matthew J.; Tasdemir, Nilgun; Dabbs, David; Jankowitz, Rachel; Hazan, Rachel; Shah, Osama; Atkinson, Jenny; Lee, Adrian V.; Oesterreich, Steffi

Quantitative comparison of immunohistochemical HER2-low detection in an interlaboratory study

HISTOPATHOLOGY

IF4.1

2024-07-29

OAAI

Hempenius, Maaike Anna; Eenkhoorn, Maran A.; Hoeg, Henrik; Dabbs, David J.; van Der Vegt, Bert; Sompuram, Seshi R.; 't Hart, Nils A.

In Support of Magnani and Taylor

ARCHIVES OF PATHOLOGY & LABORATORY MEDICINE

IF3.2

2023-12-29

OAAI

Dabbs, David J.; Chiriboga, Luis A.; Jasani, Bharat; Kinloch, Mary A.; Miller, Keith D.; Nielsen, Soren; Szabolcs, Matthias J.; Torlakovic, Emina; Bogen, Steve; Parry, Suzanne; Hart, Nils A. 't

Metaplastic breast carcinoma: a clinical-pathologic study of 97 cases with subset analysis of response to neoadjuvant chemotherapy (vol 32, pg 807, 2019)

MODERN PATHOLOGY

IF5.5

2023-08-01

OAAI

Han, Min; Salamat, Arsalan; Zhu, Li; Zhang, Huina; Clark, Beth Z.; Dabbs, David J.; Carter, Gloria J.; Brufsky, Adam M.; Jankowitz, Rachel C.; Puhalla, Shannon L.; Johnson, Ronald R.; Soran, Atilla; Steiman, Jennifer G.; McAuliffe, Priscilla F.; Diego, Emilia J.; Bhargava, Rohit

Analytical validation of the 7-gene biosignature for prediction of recurrence risk and radiation therapy benefit for breast ductal carcinoma in situ

FRONTIERS IN ONCOLOGY

IF3.3

2023-05-19

OAAI

Dabbs, David; Mittal, Karuna; Heineman, Scott; Whitworth, Pat; Shah, Chirag; Savala, Jess; Shivers, Steven C.; Bremer, Troy

7-gene predictive biosignature improves risk stratification for breast ductal carcinoma in situ patients compared to clinicopathologic criteria, identifying a low risk group not clinically benefiting from adjuvant radiotherapy

CANCER RESEARCH

IF16.6

2023-03-01

PREAI

Rabinovitch, Rachel; Vicini, Frank; Shah, Chirag; Margenthaler, Julie A.; Czerniecki, Brian J.; Whitworth, Pat; Dabbs, David J.; Mann, G. Bruce; Warnberg, Fredrik; Weinmann, Sheila; Leo, Michael; Savala, Jess; Shivers, Steven C.; Mittal, Karuna; Bremer, Troy

Characterization of recurrence risk after lumpectomy and radiotherapy in HER2-positive ductal carcinoma in situ of the breast, using 7-gene predictive biosignature: Implications for the NSABP-B43 trial results

CANCER RESEARCH

IF16.6

2023-03-01

PREAI

Vicini, Frank; Shah, Chirag; Rabinovitch, Rachel; Whitworth, Pat; Margenthaler, Julie A.; Czerniecki, Brian J.; Dabbs, David J.; Weinmann, Sheila; Leo, Michael; Mann, G. Bruce; Warnberg, Fredrik; Savala, Jess; Shivers, Steven C.; Mittal, Karuna; Bremer, Troy

Lack of Standardization in the Diagnosis of Invasive Lobular Carcinoma of the Breast

MODERN PATHOLOGY

IF5.5

2023-01-01

OAAI

Calhoun, Benjamin C.; Dabbs, David J.

A Novel Biosignature Identifies Patients With DCIS With High Risk of Local Recurrence After Breast Conserving Surgery and Radiation Therapy

INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS

IF6.5

2023-01-01

OAAI

Vicini, Frank A.; Mann, G. Bruce; Shah, Chirag; Weinmann, Sheila; Leo, Michael C.; Whitworth, Pat; Rabinovitch, Rachel; Torres, Mylin A.; Margenthaler, Julie A.; Dabbs, David; Savala, Jess; Shivers, Steven C.; Mittal, Karuna; Warnberg, Fredrik; Bremer, Troy

Novel markers in breast pathology

HISTOPATHOLOGY

IF4.1

2022-12-05

PREAI

Dabbs, David J.; Huang, Richard S.; Ross, Jeffrey S.

Deep learning models for histologic grading of breast cancer and association with disease prognosis

NPJ BREAST CANCER

IF7.6

2022-10-04

OAAI

Jaroensri, Ronnachai; Wulczyn, Ellery; Hegde, Narayan; Brown, Trissia; Flament-Auvigne, Isabelle; Tan, Fraser; Cai, Yuannan; Nagpal, Kunal; Rakha, Emad A.; Dabbs, David J.; Olson, Niels; Wren, James H.; Thompson, Elaine E.; Seetao, Erik; Robinson, Carrie; Miao, Melissa; Beckers, Fabien; Corrado, Greg S.; Peng, Lily H.; Mermel, Craig H.; Liu, Yun; Steiner, David F.; Chen, Po-Hsuan Cameron

A Consortium for Analytic Standardization in Immunohistochemistry

ARCHIVES OF PATHOLOGY & LABORATORY MEDICINE

IF3.2

2022-09-09

OAAI

Bogen, Steven A.; Dabbs, David J.; Miller, Keith D.; Nielsen, Soren; Parry, Suzanne C.; Szabolcs, Matthias J.; t'Hart, Nils; Taylor, Clive R.; Torlakovic, Emina E.

Avoiding False Positive and False Negative Immunohistochemical Results in Breast Pathology

PATHOBIOLOGY

IF2

2022-03-04

OAAI

Li, Zaibo; Dabbs, David J.

Effectiveness of aromatase inhibitors versus tamoxifen in lobular compared to ductal carcinoma: Individual patient data meta-analysis of 9328 women with central histopathology, and 7654 women with e-Cadherin status

CANCER RESEARCH

IF16.6

2022-02-15

PREAI

Hills, Robert K.; Oesterreich, Steffi; Metzger, Otto; Dabbs, David; Pan, Hongchao; Braybrooke, Jeremy; Gray, Richard; Peto, Richard; Bradley, Rosie; Straiton, Ewan; Berry, Richard; Rea, Daniel; Cameron, David; Cuzick, Jack; Regan, Meredith; Dowsett, Mitch; Sestak, Ivana; Bergh, Jonas; Swain, Sandra M.; Bartlett, John

Determining breast cancer biomarker status and associated morphological features using deep learning

COMMUNICATIONS MEDICINE

IF6.3

2021-07-14

OAAI

Gamble, Paul; Jaroensri, Ronnachai; Wang, Hongwu; Tan, Fraser; Moran, Melissa; Brown, Trissia; Flament-Auvigne, Isabelle; Rakha, Emad A.; Toss, Michael; Dabbs, David J.; Regitnig, Peter; Olson, Niels; Wren, James H.; Robinson, Carrie; Corrado, Greg S.; Peng, Lily H.; Liu, Yun; Mermel, Craig H.; Steiner, David F.; Chen, Po-Hsuan Cameron

Magee Equations™ and response to neoadjuvant chemotherapy in ER+/HER2-negative breast cancer: a multi-institutional study

MODERN PATHOLOGY

IF5.5

2021-01-01

OAAI

Bhargava, Rohit; Esposito, Nicole N.; O'Connor, Siobhan M.; Li, Zaibo; Turner, Bradley M.; Moisini, Ioana; Ranade, Aditi; Harris, Ronald P.; Miller, Dylan, V; Li, Xiaoxian; Moosavi, Harrison; Clark, Beth Z.; Brufsky, Adam M.; Dabbs, David J.

Prosigna® breast cancer assay: histopathologic correlation, development, and assessment of size, nodal status, Ki-67 (SiNK™) index for breast cancer prognosis

MODERN PATHOLOGY

IF5.5

2021-01-01

OAAI

Baskota, Swikrity Upadhyay; Dabbs, David J.; Clark, Beth Z.; Bhargava, Rohit

研究方向